 Smith Nephew PLC LSE:SN said pre-tax profit more than doubled in 2021, helped by strong sales in its sports medicine ENT and wound care segments, all of which delivered revenue higher than in pre-Coronavirus COVID-19 2019. The medical group also revealed Dr Deepak Nath was appointed as the new chief executive officer CEO, succeeding Roland Diggelmann, who will step down by mutual agreement. 